381349292	381349292	CD	B-NP	O
|	|	NN	I-NP	O
OH	OH	NN	I-NP	O
|	|	NN	I-NP	O
48802763	48802763	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
580488	580488	CD	B-NP	O
|	|	CC	I-NP	O
4/10/1995	4/10/1995	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/10/1995	4/10/1995	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/3/1995	10/3/1995	CD	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSES	DIAGNOSES	NN	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	NN	B-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
GASTRIC	GASTRIC	NN	I-NP	O
REFLUX	REFLUX	NN	I-NP	O
DISEASE	DISEASE	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
2	2	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HYPERTENSION	HYPERTENSION	NN	I-NP	O
,	,	,	O	O
15	15	CD	B-NP	O
YEARS	YEARS	NNS	I-NP	O
-LRB-	-LRB-	SYM	O	O
3	3	CD	B-NP	O
-RRB-	-RRB-	SYM	I-NP	O
ADULT	ADULT	NN	I-NP	O
ONSET	ONSET	NN	I-NP	O
DIABETES	DIABETES	NNP	I-NP	O
MELLITUS	MELLITUS	NNP	I-NP	O
,	,	,	O	O
NON-INSULIN	NON-INSULIN	NNP	B-NP	B-protein
DEPENDENT	DEPENDENT	NNP	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
-	-	HYPH	I-NP	O
2	2	CD	I-NP	O
YEARS	YEARS	NNS	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HYPERCHOLESTEROLEMIA	HYPERCHOLESTEROLEMIA	NN	I-NP	O
,	,	,	O	O
TREATED	TREATED	VBN	B-VP	O
FOR	FOR	IN	B-PP	O
4	4	CD	B-NP	O
YEARS	YEARS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
5	5	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
MYOCARDITIS	MYOCARDITIS	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
6	6	CD	B-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
STATUS	STATUS	NNP	I-NP	O
POST	POST	NNP	I-NP	O
TOTAL	TOTAL	NNP	I-NP	O
ABDOMINAL	ABDOMINAL	NNP	I-NP	O
HYSTERECTOMY/BILATERAL	HYSTERECTOMY/BILATERAL	NNP	I-NP	O
SALPINGO-OOPHORECTOMY	SALPINGO-OOPHORECTOMY	NNP	I-NP	O
IN	IN	NNP	I-NP	O
1975	1975	CD	I-NP	O
WITHOUT	WITHOUT	NNP	I-NP	O
ESTROGEN	ESTROGEN	NNP	I-NP	O
REPLACEMENT	REPLACEMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7	7	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
DEPRESSION	DEPRESSION	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	SYM	I-NP	O
MULTIPLE	MULTIPLE	NN	I-NP	O
FOOD	FOOD	NN	I-NP	O
AND	AND	CC	B-NP	O
ENVIRONMENTAL	ENVIRONMENTAL	JJ	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57	57	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
with	with	IN	B-PP	O
complaint	complaint	NN	B-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
relieved	relieve	VBN	B-VP	O
by	by	IN	B-PP	O
two	two	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerins	nitroglycerin	NNS	I-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
are	be	VBP	B-VP	O
hypertension	hypertension	NN	B-NP	O
,	,	,	O	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
,	,	,	O	O
tobacco	tobacco	NN	B-NP	O
use	use	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
hypercholesterolemia	hypercholesterolemia	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
early	early	JJ	B-NP	O
menopause	menopause	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
estrogen	estrogen	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
on	on	IN	B-PP	O
11/10/95	11/10/95	CD	B-NP	O
with	with	IN	B-PP	O
complaint	complaint	NN	B-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
at	at	IN	B-PP	O
rest	rest	NN	B-NP	O
without	without	IN	B-PP	O
associated	associate	VBN	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
decreased	decrease	VBN	B-NP	O
exercise	exercise	NN	I-NP	O
tolerance	tolerance	NN	I-NP	O
,	,	,	O	O
exertional	exertional	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
PND	PND	NN	I-NP	B-protein
,	,	,	O	O
edema	edema	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
vomiting	vomiting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
diaphoresis	diaphoresis	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
complaint	complaint	NN	I-NP	O
at	at	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
was	be	VBD	B-VP	O
3	3	CD	B-NP	O
out	out	IN	I-NP	O
of	of	IN	I-NP	O
10	10	CD	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
which	which	WDT	B-NP	O
spontaneously	spontaneously	RB	B-ADVP	O
resolved	resolve	VBD	B-VP	O
.	.	.	O	O

It	It	PRP	B-NP	O
recurred	recur	VBD	B-VP	O
intermittently	intermittently	RB	B-ADVP	O
without	without	IN	B-PP	O
associated	associated	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
and	and	CC	I-NP	O
EKG	EKG	NN	I-NP	B-protein
.	.	.	O	O

CKs	CK	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
156	156	CD	B-NP	O
,	,	,	I-NP	O
135	135	CD	I-NP	O
,	,	,	O	O
and	and	CC	O	O
108	108	CD	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blockers	blocker	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
concern	concern	NN	I-NP	O
was	be	VBD	B-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
unequal	unequal	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
and	and	CC	I-NP	O
complaint	complaint	NN	I-NP	O
of	of	IN	B-PP	O
back	back	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
GEE	GEE	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
to	to	TO	I-VP	O
rule	rule	VB	I-VP	O
out	out	RP	B-PRT	O
aortic	aortic	JJ	B-NP	O
dissection	dissection	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
GEE	GEE	NNP	B-NP	O
there	there	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
valvular	valvular	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
or	or	CC	I-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
dissection	dissection	NN	B-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
regional	regional	JJ	I-NP	O
wall	wall	NN	I-NP	O
motion	motion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

ETT	ETT	NN	B-NP	B-protein
was	be	VBD	B-VP	O
done	do	VBN	I-VP	O
on	on	IN	B-PP	O
8/26/95	8/26/95	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
exercised	exercise	VBN	B-VP	O
for	for	IN	B-PP	O
4	4	CD	B-NP	O
minutes	minute	NNS	I-NP	O
13	13	CD	B-NP	O
seconds	second	NNS	I-NP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
standard	standard	JJ	I-NP	O
Bruce	Bruce	NNP	I-NP	O
protocol	protocol	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
stopped	stop	VBN	I-VP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
leg	leg	NN	B-NP	O
fatigue	fatigue	NN	I-NP	O
and	and	CC	O	O
dyspnea	dyspnea	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
of	of	IN	B-PP	O
84	84	CD	B-NP	O
-	-	HYPH	O	O
113	113	CD	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
target	target	NN	I-NP	O
of	of	IN	B-PP	O
138	138	CD	B-NP	O
.	.	.	O	O

Blood	Blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
was	be	VBD	B-VP	O
136/80	136/80	CD	B-NP	O
and	and	CC	O	O
elevated	elevate	VBD	B-VP	O
to	to	TO	B-PP	O
164/90	164/90	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
evidence	evidence	NN	I-NP	O
for	for	IN	B-PP	O
ischemia	ischemia	NN	B-NP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
study	study	NN	I-NP	O
despite	despite	IN	B-PP	O
limited	limited	JJ	B-NP	O
effort	effort	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
evening	evening	NN	I-NP	O
of	of	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
7/25/95	7/25/95	CD	B-NP	O
she	she	PRP	B-NP	O
again	again	RB	B-ADVP	O
had	have	VBD	B-VP	O
the	the	DT	B-NP	O
acute	acute	JJ	I-NP	O
onset	onset	NN	I-NP	O
of	of	IN	B-PP	O
sharp	sharp	JJ	B-NP	O
,	,	,	O	O
burning	burn	VBG	B-VP	O
,	,	,	O	O
mid-epigastric	mid-epigastric	JJ	B-ADJP	O
versus	versus	IN	B-PP	O
sternal	sternal	JJ	B-NP	O
pain	pain	NN	I-NP	O
without	without	IN	B-PP	O
radiation	radiation	NN	B-NP	O
and	and	CC	B-PP	O
with	with	IN	B-PP	O
associated	associate	VBN	B-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
,	,	,	O	O
nausea	nausea	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
an	an	DT	B-NP	O
acid	acid	NN	I-NP	O
taste	taste	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
two	two	CD	B-NP	O
sublingual	sublingual	JJ	I-NP	O
nitroglycerins	nitroglycerin	NNS	I-NP	O
with	with	IN	B-PP	O
relief	relief	NN	B-NP	O
of	of	IN	B-PP	O
symptoms	symptom	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
pain	pain	NN	I-NP	O
lasted	last	VBD	B-VP	O
a	a	DT	B-NP	O
total	total	NN	I-NP	O
of	of	IN	B-PP	O
15	15	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
pain-free	pain-free	JJ	B-ADJP	O
since	since	IN	B-SBAR	O
arrival	arrival	NN	B-NP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
Glucotrol	Glucotrol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Cardizem	Cardizem	NNP	B-NP	O
CD	CD	NNP	I-NP	O
,	,	,	O	O
Benadryl	Benadryl	NNP	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
Provastatin	Provastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Hydrochlorothiazide	Hydrochlorothiazide	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Trazadone	Trazadone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
aspirin	aspirin	NN	B-NP	O
1	1	CD	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Lopressor	Lopressor	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
nitroglycerin	nitroglycerin	NN	B-NP	O
sublingual	sublingual	JJ	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
Ambien	Ambien	IN	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
ALLERGIES	ALLERGIES	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
.	.	.	O	O

SOCIAL	SOCIAL	JJ	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
receptionist	receptionist	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
three	three	CD	B-NP	O
children	child	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
has	have	VBZ	B-VP	O
never	never	RB	I-VP	O
married	marry	VBN	I-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
lives	live	VBZ	B-VP	O
alone	alone	RB	B-ADVP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	JJ	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
with	with	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
of	of	IN	B-PP	O
132/96	132/96	CD	B-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
95	95	CD	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
on	on	IN	B-PP	O
one	one	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
oxygen	oxygen	NN	B-NP	O
,	,	,	O	O
saturation	saturation	NN	B-NP	O
of	of	IN	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
was	be	VBD	B-VP	O
20	20	CD	B-NP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
:	:	:	O	O
Normal	Normal	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
JVD	JVD	NN	I-NP	B-protein
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NNP	B-NP	O
:	:	:	O	O
PMI	PMI	NN	B-NP	O
was	be	VBD	B-VP	O
nondisplaced	nondisplaced	JJ	B-ADJP	O
.	.	.	O	O

Normal	Normal	JJ	B-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	I-NP	O
S2	S2	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
S3	S3	NN	I-NP	B-protein
or	or	CC	I-NP	O
S4	S4	NN	I-NP	B-protein
.	.	.	O	O

No	No	DT	B-NP	O
murmurs	murmur	NNS	I-NP	O
,	,	,	O	O
gallops	gallop	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
rubs	rub	NNS	B-NP	O
.	.	.	O	O

Abdomen	Abdoman	NNS	B-NP	O
:	:	:	O	O
Soft	Soft	JJ	B-ADJP	O
but	but	CC	I-ADJP	O
obese	obese	JJ	I-ADJP	O
.	.	.	O	O

Nontender	Nontender	RB	B-ADVP	O
,	,	,	O	O
nondistended	nondistended	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
hepatojugular	hepatojugular	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
abdominal	abdominal	JJ	I-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
pulsatile	pulsatile	JJ	I-NP	O
masses	mass	NNS	I-NP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
:	:	:	O	O
Without	Without	IN	B-PP	O
edema	edema	NN	B-NP	O
,	,	,	O	O
cords	cord	NNS	B-NP	O
,	,	,	O	O
or	or	CC	O	O
femoral	femoral	JJ	B-NP	O
bruits	bruit	NNS	I-NP	O
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
:	:	:	O	O
Notable	Notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
potassium	potassium	NN	B-NP	O
of	of	IN	B-PP	O
3.7	3.7	CD	B-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
1.9	1.9	CD	I-NP	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	B-protein
36	36	CD	I-NP	I-protein
,	,	,	O	O
WBC	WBC	NNP	B-NP	O
11.5	11.5	CD	I-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	O
first	first	JJ	I-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
118	118	CD	B-NP	O
.	.	.	O	O

Triponin	Triponin	NN	B-NP	B-protein
was	be	VBD	B-VP	O
0.0	0.0	CD	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
with	with	IN	B-PP	O
occasional	occasional	JJ	B-NP	O
PVCs	PVC	NNS	I-NP	O
.	.	.	O	O

Intervals	Interval	NNS	B-NP	O
and	and	CC	I-NP	O
axis	axis	NN	I-NP	O
were	be	VBD	B-VP	O
within	within	IN	B-PP	O
normal	normal	JJ	B-NP	O
limits	limit	NNS	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
slight	slight	JJ	I-NP	O
upper	upper	JJ	I-NP	O
concavity	concavity	NN	I-NP	O
and	and	CC	I-NP	O
ST-T	ST-T	NN	I-NP	B-protein
segment	segment	NN	I-NP	I-protein
in	in	IN	B-PP	O
V2	V2	NN	B-NP	O
and	and	CC	I-NP	O
V3	V3	NN	I-NP	B-protein
when	when	WRB	B-ADVP	O
compared	compare	VBN	B-VP	O
to	to	TO	B-PP	O
old	old	JJ	B-ADJP	O
although	although	IN	B-SBAR	O
this	this	DT	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
J	J	NN	B-NP	O
point	point	NN	I-NP	O
elevation	elevation	NN	I-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
0.5	0.5	CD	I-NP	O
mm	mm	NN	I-NP	O
segment	segment	NN	I-NP	O
elevation	elevation	NN	I-NP	O
in	in	IN	B-PP	O
V2	V2	NN	B-NP	B-protein
.	.	.	O	O

The	The	DT	B-NP	O
EKG	EKG	NN	I-NP	B-protein
was	be	VBD	B-VP	O
without	without	IN	B-PP	O
change	change	NN	B-NP	O
from	from	IN	B-PP	O
previous	previous	JJ	B-NP	O
admission	admission	NN	I-NP	O
.	.	.	O	O

IMPRESSION	IMPRESSION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
57	57	CD	I-NP	O
year	year	NN	I-NP	O
old	old	JJ	I-NP	O
woman	woman	NN	I-NP	O
with	with	IN	B-PP	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	B-protein
risk	risk	NN	I-NP	I-protein
factors	factor	NNS	I-NP	I-protein
presenting	present	VBG	B-VP	O
with	with	IN	B-PP	O
complaint	complaint	NN	B-NP	O
of	of	IN	B-PP	O
substernal	substernal	JJ	B-NP	O
,	,	,	I-NP	O
midepigastric	midepigastric	JJ	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
burning	burning	NN	B-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
she	she	PRP	B-NP	O
had	have	VBD	B-VP	O
multiple	multiple	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
risk	risk	NN	I-NP	O
factors	factor	NNS	I-NP	O
,	,	,	O	O
her	her	PRP$	B-NP	O
pain	pain	NN	I-NP	O
is	be	VBZ	B-VP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
atypical	atypical	JJ	I-NP	O
quality	quality	NN	I-NP	O
and	and	CC	O	O
sounds	sound	VBZ	B-VP	O
more	more	RBR	B-ADJP	O
consistent	consistent	JJ	I-ADJP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
source	source	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
GEE	GEE	NNP	I-NP	O
was	be	VBD	B-VP	O
a	a	DT	B-NP	O
suboptimal	suboptimal	JJ	I-NP	O
study	study	NN	I-NP	O
and	and	CC	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
deemed	deem	VBN	I-VP	O
more	more	RBR	B-ADJP	O
appropriate	appropriate	JJ	I-ADJP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
to	to	TO	B-PP	O
both	both	DT	B-NP	O
rule	rule	NN	I-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
out	out	RP	B-PRT	O
but	but	CC	O	O
consider	consider	VB	B-VP	O
a	a	DT	B-NP	O
pharmacologic	pharmacologic	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
before	before	IN	B-PP	O
cathing	cathe	VBG	B-VP	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
Since	Since	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
symptoms	symptom	NNS	I-NP	O
did	do	VBD	B-VP	O
sound	sound	VB	I-VP	O
more	more	RBR	B-ADJP	O
gastrointestinal	gastrointestinal	JJ	I-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
on	on	IN	B-PP	O
Axid	Axid	NN	B-NP	O
for	for	IN	B-PP	O
possibility	possibility	NN	B-NP	O
of	of	IN	B-PP	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
provided	provide	VBN	B-VP	O
with	with	IN	B-PP	O
Maalox	Maalox	NNP	B-NP	O
and	and	CC	O	O
told	tell	VBD	B-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
the	the	DT	B-NP	O
head	head	NN	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
bed	bed	NN	I-NP	O
elevated	elevate	VBD	B-VP	O
.	.	.	O	O

She	She	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Glucotrol	Glucotrol	NN	B-NP	O
for	for	IN	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
instructed	instruct	VBN	I-VP	O
on	on	IN	B-PP	O
risk	risk	NN	B-NP	O
factor	factor	NN	I-NP	O
modifications	modification	NNS	I-NP	O
,	,	,	O	O
including	include	VBG	B-PP	O
diabetes	diabetes	NN	B-NP	O
mellitus	mellitus	NN	I-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
controlling	control	VBG	B-VP	O
cholesterol	cholesterol	NN	B-NP	O
and	and	CC	I-NP	O
hypertension	hypertension	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
is	be	VBZ	B-VP	O
currently	currently	RB	B-ADVP	O
a	a	DT	B-NP	O
non-smoker	non-smoker	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
following	follow	VBG	B-PP	O
admission	admission	NN	B-NP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
ruled	rule	VBN	I-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
infarction	infarction	NN	I-NP	O
by	by	IN	B-PP	O
enzyme	enzyme	NN	B-NP	O
sets	set	NNS	I-NP	O
respectively	respectively	RB	B-ADVP	O
.	.	.	O	O

A	A	DT	B-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
118	118	CD	B-NP	O
;	;	:	O	O
B	B	NN	B-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
105	105	CD	B-NP	O
;	;	:	O	O
C	C	NN	B-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
105	105	CD	B-NP	O
;	;	:	O	O
D	D	NN	B-NP	O
set	set	NN	I-NP	O
was	be	VBD	B-VP	O
100	100	CD	B-NP	O
.	.	.	O	O

EKGs	EKG	NNS	B-NP	B-protein
were	be	VBD	B-VP	O
without	without	IN	B-PP	O
change	change	NN	B-NP	O
.	.	.	O	O

As	As	RB	B-ADVP	O
well	well	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
remained	remain	VBN	I-VP	O
symptom-free	symptom-free	JJ	B-ADJP	O
during	during	IN	B-PP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
course	course	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
scheduled	schedule	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
Dobutamine	Dobutamine	NN	I-NP	O
MIBI	MIBI	NN	I-NP	O
for	for	IN	B-PP	O
6/23/95	6/23/95	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
on	on	IN	B-PP	O
Dobutamine	Dobutamine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
study	study	NN	I-NP	O
showed	show	VBD	B-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
going	go	VBG	B-VP	O
up	up	RB	B-ADVP	O
from	from	IN	B-PP	O
70	70	CD	B-NP	O
to	to	TO	B-PP	O
101	101	CD	B-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
170/80	170/80	CD	I-NP	O
went	go	VBD	B-VP	O
up	up	RB	B-ADVP	O
to	to	TO	B-PP	O
230/90	230/90	CD	B-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
changes	change	NNS	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	O
images	image	NNS	I-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
fixed	fix	VBN	I-NP	O
mild	mild	JJ	I-NP	O
reduced	reduce	VBN	I-NP	O
uptake	uptake	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
inferior	inferior	JJ	I-NP	O
wall	wall	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
but	but	CC	B-NP	O
not	not	RB	I-NP	O
diagnostic	diagnostic	JJ	B-ADJP	O
for	for	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
injury	injury	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
reversible	reversible	JJ	I-NP	O
perfusion	perfusion	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
detected	detect	VBN	B-VP	O
.	.	.	O	O

As	As	IN	B-SBAR	O
such	such	JJ	B-NP	O
the	the	DT	I-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-ADVP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
change	change	NN	I-NP	O
in	in	IN	B-PP	O
her	her	PRP$	B-NP	O
medication	medication	NN	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Atenolol	Atenolol	NN	B-NP	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Ecasa	Ecasa	NNP	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Glucotrol	Glucotrol	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	RB	B-ADVP	O
,	,	,	O	O
Hydrochlorothiazide	Hydrochlorothiazide	NNP	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Trazadone	Trazadone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
,	,	,	O	O
Axid	Axid	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
Provastatin	Provastatin	NN	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-NP	O
q.d.	q.d.	FW	I-NP	O
FOLLOW-UP	FOLLOW-UP	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
follow-up	follow-up	VB	I-VP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Jonker	Jonker	NNP	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
workup	workup	NN	I-NP	O
and	and	CC	I-NP	O
management	management	NN	I-NP	O
of	of	IN	B-PP	O
gastroesophageal	gastroesophageal	JJ	B-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
following	follow	VBG	B-VP	O
her	her	PRP	B-NP	O
for	for	IN	B-PP	O
her	her	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
disease	disease	NN	I-NP	O
via	via	IN	B-PP	O
the	the	DT	B-NP	O
risk	risk	NN	I-NP	O
factor	factor	NN	I-NP	O
modification	modification	NN	I-NP	O
.	.	.	O	O

Dictated	Dictate	VBN	B-VP	O
By	By	IN	B-PP	O
:	:	:	O	O
MAC	MAC	NNP	B-NP	O
MCKAMIE	MCKAMIE	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CC04	CC04	NNP	I-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
RAY	RAY	NNP	B-NP	O
B.	B.	NNP	I-NP	O
DUNWOODY	DUNWOODY	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DF35	DF35	NNP	I-NP	O
ZJ236/6467	ZJ236/6467	NNP	I-NP	O
Batch	Batch	NNP	I-NP	O
:	:	:	O	O
60202	60202	CD	B-NP	O
Index	Index	NNP	I-NP	O
No	No	NNP	I-NP	O
.	.	.	O	O

YMTDDR97V1	YMTDDR97V1	NN	B-NP	O
D	D	NN	I-NP	O
:	:	:	O	O
9/30/96	9/30/96	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
8/28/96	8/28/96	CD	B-NP	O

